Related Experiment Video
Updated: May 17, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization
Rui Jia1, Qinghua Pan, Shilei Ding
1Key Laboratory of Molecular Microbiology and Biotechnology (Ministry of Education) and Key Laboratory of Microbial Functional Genomics (Tianjin), College of Life Sciences, Nankai University, Tianjin, China.
Abstract:
Interferon-inducible transmembrane (IFITM) protein family members IFITM1, -2, and -3 restrict the infection of multiple enveloped viruses. Significant enrichment of a minor IFITM3 allele was recently reported for patients who were hospitalized for seasonal and 2009 H1N1 pandemic flu. This IFITM3 allele lacks the region corresponding to the first amino-terminal 21 amino acids and is unable to inhibit influenza A virus. In this study, we found that deleting this 21-amino-acid region relocates IFITM3 from the endosomal compartments to the cell periphery. This finding likely underlies the lost inhibition of influenza A virus that completes its entry exclusively within endosomes at low pH. Yet, wild-type IFITM3 and the mutant with the 21-amino-acid deletion inhibit HIV-1 replication equally well. Given the pH-independent nature of HIV-1 entry, our results suggest that IFITM3 can inhibit viruses that enter cells via different routes and that its N-terminal region is specifically required for controlling pH-dependent viruses.
Insights
Interferon-inducible transmembrane protein 3 (IFITM3) variants affect viral restriction. A specific IFITM3 variant lacking N-terminal amino acids impairs influenza A virus inhibition by altering protein localization, but not HIV-1 inhibition.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Interferon-inducible transmembrane (IFITM) proteins restrict enveloped virus infections.
- A specific IFITM3 allele, lacking the N-terminal 21 amino acids, is associated with severe flu outcomes and fails to inhibit influenza A virus.
- Viral entry mechanisms, including pH-dependent and independent pathways, influence susceptibility to IFITM-mediated restriction.
Purpose of the Study:
- To investigate the functional role of the N-terminal 21 amino acids of IFITM3 in viral restriction.
- To determine how the deletion of the N-terminal region affects IFITM3 localization and its ability to inhibit different viruses.
- To elucidate the mechanism by which IFITM3 restricts pH-dependent and pH-independent viral entry.
Main Methods:
- Site-directed mutagenesis to create an IFITM3 mutant lacking the N-terminal 21 amino acids.
- Confocal microscopy to assess the subcellular localization of wild-type and mutant IFITM3.
- Viral infection assays using influenza A virus and HIV-1 to evaluate antiviral activity.
Main Results:
- Deletion of the N-terminal 21 amino acids of IFITM3 caused its relocation from endosomal compartments to the cell periphery.
- The N-terminal deletion mutant lost the ability to inhibit influenza A virus, which enters cells via low pH-dependent endosomes.
- Both wild-type IFITM3 and the N-terminal deletion mutant exhibited equal efficacy in inhibiting HIV-1 replication, which enters cells via a pH-independent route.
Conclusions:
- The N-terminal region of IFITM3 is specifically required for restricting viruses that utilize pH-dependent entry pathways, such as influenza A virus.
- IFITM3 can inhibit viruses employing diverse entry mechanisms, with its N-terminal domain playing a critical role in targeting specific routes.
- Understanding IFITM3's differential activity based on viral entry mechanisms provides insights into host antiviral defense strategies.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Intralumenal Vesicles and Multivesicular Bodies
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Tail-anchoring of Proteins in the ER Membrane
Regulated mRNA Transport
Regulation of Nuclear Protein Sorting

